Pages that link to "Q39834307"
Jump to navigation
Jump to search
The following pages link to beta-Lactamases and beta-lactam resistance in Escherichia coli (Q39834307):
Displayed 35 items.
- beta-Lactamases in laboratory and clinical resistance (Q24669605) (← links)
- Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae (Q24674937) (← links)
- Patterns and mechanisms of beta-lactam resistance among isolates of Escherichia coli from hospitals in the United States (Q24676380) (← links)
- Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome (Q33750327) (← links)
- Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their beta-lactamases. Canadian Haemophilus Study Group (Q33755888) (← links)
- Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli (Q33976746) (← links)
- Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics (Q35111391) (← links)
- Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2). (Q35125797) (← links)
- Borderline methicillin-susceptible Staphylococcus aureus strains have more in common than reduced susceptibility to penicillinase-resistant penicillins (Q35130024) (← links)
- Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases (Q35254248) (← links)
- Detection of plasmid-mediated beta-lactamases with DNA probes (Q35291064) (← links)
- Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection (Q35538487) (← links)
- Properties of a novel carbenicillin-hydrolyzing beta-lactamase (CARB-4) specified by an IncP-2 plasmid from Pseudomonas aeruginosa (Q35649062) (← links)
- In vitro activity of cefepime against multidrug-resistant Gram-negative bacilli, viridans group streptococci and Streptococcus pneumoniae from a cross-Canada surveillance study (Q35649669) (← links)
- Comparative activity of cefepime with several antimicrobials against aerobic Gram-negative and Gram-positive organisms isolated from patients across Canada in 1993. (Q35893006) (← links)
- In vivo acquisition of high-level resistance to imipenem in Escherichia coli (Q37156252) (← links)
- Integron mobilization unit as a source of mobility of antibiotic resistance genes (Q37204188) (← links)
- Ertapenem resistance of Escherichia coli (Q37302659) (← links)
- Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles (Q39475024) (← links)
- Mechanisms of resistance to cephalosporin antibiotics (Q39685326) (← links)
- Effects of beta-lactamases and omp mutation on susceptibility to beta-lactam antibiotics in Escherichia coli (Q39815088) (← links)
- Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins (Q39818693) (← links)
- Monoclonal antibodies to TEM-1 plasmid-mediated beta-lactamase (Q39829069) (← links)
- Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329 (Q40088008) (← links)
- Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. (Q40389382) (← links)
- Cefepime clinical pharmacokinetics (Q40861609) (← links)
- Quorum-sensing regulator sdiA and marA overexpression is involved in in vitro-selected multidrug resistance of Escherichia coli (Q43098014) (← links)
- Detection of amp C in Enterobacter cloacae in China (Q43787273) (← links)
- Molecular diversity and evolution of blaTEM genes encoding beta-lactamases resistant to clavulanic acid in clinical E. coli (Q48056264) (← links)
- Problems in interpretation of piperacillin susceptibility of TEM-1 producingEscherichia coli in the disk diffusion test (Q54283666) (← links)
- The influence of clinical use of antibiotics and the sensitivity of strains isolated from postoperative infections--a comparison of nosocomial pathogens with strains isolated from the bacterial flora of patients. (Q54292677) (← links)
- In vitro activity and beta-lactamase stability of LY163892. (Q54379306) (← links)
- Piperacillin/tazobactam in complicated urinary tract infections. (Q54631175) (← links)
- Synergistic effect of dosage and bacterial inoculum in TEM-1 mediated antibiotic resistance (Q67232003) (← links)
- Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2 (Q92677555) (← links)